Funder: Novo Nordisk

Due Dates: September 2, 2025 (Full application submission deadline)

Funding Amounts: DKK 8–12 million per project (4 years); up to DKK 50 million total; one project may receive an additional DKK 2 million for consortium activities.

Summary: Funds collaborative research by basic and clinical scientists to uncover molecular mechanisms linking obesity and cancer, fostering a consortium for knowledge exchange.

Key Information: Main applicant must be based in Denmark; co-applicant may be from the EEA, UK, or Switzerland; both must be from non-profit institutions.